DUBLIN--(BUSINESS WIRE)--The "Global Veterinary Paraciticides Market - segmented by disease causing organisms, By products, By animal types & by Geography - Trends & Forecasts ." report has been added to Research and Markets' offering.
The global veterinary parasiticides market was valued at USD 2,714 million in 2014 and is projected to reach USD 5,121million by 2020, at a CAGR of 11.16% during the forecast period from 2014 to 2019.
Veterinary pharmaceuticals, including parasiticides, have transformed the health of companion and livestock animals across the globe over the past two decades. Today, the spectrum of parasiticides for veterinary applications continues to expand with a variety of ectoparasiticides, endoparasiticides, and endectocides that are launched every year. Constant innovations are leading to the emergence of novel parasiticide delivery systems as well in this market.
Market Drivers:
- Increase in pet ownership
- Improved nutrition
- Intensifying consumer focus on food safety
- Greater livestock production rates
- Increasing food-borne diseases
Market Restraints:
- Scarcity of arable land and water
- Increased competition for cultivated land
- Increased competition for cost-effective production
Companies Mentioned:
- Zoetis animal healthcare
- Merck
- Merial (Animal Health Division Of Sanofi)
- Elanco
- Bayer healthcare
- Ceva Animal Health, Inc.
- Virbac
- Boehringer Ingelheim
Key Topics Covered:
1. Introduction
2. Market Analysis
3. Market Dynamics
4.Global Veterinary Parasiticides Market Segmentation
5. Competitive Landscape
6. Company Profiles
7. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/w84whk/global_veterinary
